This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This randomized clinical trial assesses whether cardioverter-defibrillator implantation is more effective than amiodarone therapy for the primary prevention of all-cause mortality and secondary prevention of suddencardiacdeath, hospitalization for heart failure, and use of a pacemaker among patients with chronic Chagas cardiomyopathy.
A heart attack is a life-threatening condition, with patients remaining at risk of premature death long after the actual attack—50% to 60% of patients die subsequently as a result of suddencardiacdeath, triggered by cardiac arrhythmia.
The following are key points to remember from a review article on cardiac implantable electronic devices (CIEDs), which include pacemakers for bradycardia, biventricular pacemakers for heart failure, and implantable cardioverter–defibrillators (ICDs) for the treatment of suddencardiacdeath:
Pathogenic genetic variants in the HCN4 (hyperpolarisation-activated and cyclic nucleotide-gated channel) gene can cause sinus node dysfunction, disrupting the function of the pacemaker region of the heart. Patients with such variants can present with a wide spectrum of arrhythmias but suddendeath is generally considered rare.
CS has a range of clinical syndromes: impaired conduction, arrhythmias, heart failure, and suddencardiacdeath. She underwent pacemaker implantation with mild improvement of symptoms. She underwent surgical resection of the cardiac mass. cm in size.
Isoprenalin was discontinued, and a temporary transveous pacemaker was implanted. The patient stabilized following pacemaker placement. SCD (suddencardiacdeath) from sarcoid heart disease is thought to be caused by either from high-grade AV block or VT. The above ECG initially shows AV block.
He said a screening test called cardiac-arrhythmic genome analysis is available in certain European centers. The role of the molecular autopsy in suddencardiacdeath in young individuals. Ref: Isbister, J.C., Semsarian, C. Nat Rev Cardiol 21 , 215–216 (2024).
2:34 PM, following right heart catheterization She then went into atrial fibrillation with complete heart block and junctional escape rhythm prompting placement of transvenous pacemaker. The catheter was out of the body and the arteriotomy had been closed, so there is no pressure waveform. In the midst of this, she went into VF.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content